Revisiting the role of vitamin D levels in the prevention of COVID-19 infection and mortality in European countries post infections peak

doi:10.21203/rs.3.rs-32484/v1

Download PDF

Short Report

Revisiting the role of vitamin D levels in the prevention of COVID-19 infection and mortality in European countries post infections peak

https://doi.org/10.21203/rs.3.rs-32484/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 01 Aug, 2020

Read the published version in Aging Clinical and Experimental Research →

Version 1

posted

You are reading this latest preprint version

Various studies are underway to identify protective variables for the COVID-19 pandemic. We hypothesized that if indeed the Vitamin D levels would be protective in the European population, as recently proposed, the correlation would become more robust when the countries had passed the infection peak as on May 12, 2020, compared to April 8, 2020, when the majority had not. Comparative analysis of data from the mentioned stages indicated a significant increase in negative correlation of vitamin D levels with COVID-19 cases per million population in later stage (r(20): -0.5504; R²=0.3029; p-value: 0.0119 vs r(20): -0.4435; R²=0.1967; p-value: 0.0501) whereas the correlation with deaths per million population became insignificant (r(20): -0.3935; R²=0.1549; p-value: 0.0860 vs r(20): -0.4378; R²=0.1917; p-value: 0.0535). Considering divergence of vitamin D levels from the mean in subgroups, e.g. children, women, aged, dedicated exploratory studies with carefully chosen matched target groups is advisable.

Infectious Diseases

COVID-19

SARS-CoV-2

Correlation

Vitamin D

Europe

The COVID–19 pandemic caused by the novel coronavirus SARS-CoV–2 has taken the world by surprise. The spread of COVID–19 (SARS-CoV–2) has been rapid with significant tolls in comparison to earlier coronavirus pandemic/outbreaks. It has already infected more than 4.25 million and killed about 287 thousand people by 12^th May 2020 [1]. The severity of COVID–19 and its spread has been muted in African, Asian, and South American countries. Recently, a peer-review publication had negatively correlated the serum Vitamin D level in European countries with reported COVID–19 infection cases and deaths per million populations [2]. Vitamin D is known to exert a positive effect on the immunity and general health of individuals [3]. It had been indicated to protect from other acute respiratory tract infections and the adverse outcomes [4,5]. It has been indicated to do that through a multitude of effects including increasing the oxygen-carrying capacity of the blood, modulating the immune system, expediting the recovery from acute lung injury and modulation of renin-angiotensin system including the ACE2 [6], the receptor of SARS-CoV–2 [7]

The association Vitamin D levels with COVID–19 incidence and severity had been investigated recently [2]. A protective correlation with mean Vitamin D levels in select European countries had been suggested using COVID–19 data from April 8, 2020 when all countries were not at the same stage of the current wave of infections [1]. We hypothesized if indeed such a protective correlation exists it would become more robust with the passage of time when all countries reach a similar stage of the COVID–19 pandemic. The primary aim of this study was to reevaluate the protective effect of vitamin D levels on the European population. The secondary aim was to ascertain if it had any impact on the number of cases. Our analysis of the countries indicated a significant negative correlation between Vitamin D levels with COVID–19 cases but an insignificant negative correlation with adverse disease outcome (mortality).

The countries of Europe with comparable UV exposure and dietary intake were chosen for the analysis for decreasing the effect of confounding variables as expected in such studies as done previously[2]. The data about COVID–19 cases per million of population and deaths per million of the population (Table 1) were obtained for 8 April and 12 May 2020 from worldwide coronavirus pandemic data portal at https://www.worldometers.info/coronavirus/ [1]. The data for mean serum vitamin D levels was from a previous publication [2]. The Microsoft excel was used for making basic statistic calculations (linear regression analysis - calculation of best-fit trend line for data, the R- squared value (R²); and Pearson correlation coefficient).

For the countries studied, we observed a stronger negative correlation between vitamin D levels and COVID–19 cases post COVID–19 infections peak on 12 May 2020, as compared to that observed on 8 April 2020 (Table 2). However, the negative correlation with deaths per million population seemed to be insignificant. Please see Table 2 for comparative correlation (linear regression) at different stages of pandemic and Figure 1 for exponential correlative inference (R² = 0.3751).

nbsp;

Vitamin D had been known to affect the immune system and decrease the severity of respiratory tract infections [4–6]. Recent correlative analysis investigating the effect of mean serum levels on the COVID–19 occurrence/cases and deaths in European countries had indicated a tenuous negative (protective) covariation [2]. The level of significance for correlation was borderline (p-value 0.0501 and 0.0534) as could be expected from countries included in the study being at different stages of the COVID–19 pandemic. For making the covariation analysis more robust, the data about cases and deaths per million population was also gathered from a later date, i.e., 12 May 2020, when the COVID–19 situation had stabilized and countries had passed the peak of the infection. It was found that the cases per million had registred about 1.2 fold (e.g., Iceland, Norway) to 4 fold increase (Ireland, Hungary, Turkey) while the death rates registered about 1.6 fold (e.g., Iceland) to 12.5 fold (e.g.,, Slovakia) increase (Table 1). The standard deviation of the data mean had also reduced (Table 1). The strength and significance of correlation changed both between vitamin D levels and cases per million (r(20): –0.4435; R² = 0.1967; p-value: 0.0501 vs r(20): –0.5504; R² = 0.3029; p-value: 0.0119) as well as between vitamin D and deaths per million (r(20): –0.4378; R² = 0.1917; p-value: 0.0535 vs r(20): –0.3935; R² = 0.1549; p-value: 0.0860). The exponential curve fitting of the data displayed still better correlation with cases per million (R² = 0.3751) and deaths per million (R² = 0.2754), as expected for a biological system with bottlenecks and required thresholds for seeing an effect (Figure 1). There is a possibility that there exists a cause and effect relationship.

The underlying differences in the population composition, age distribution, differential comorbidities distribution, medication practices, etc maybe some other confounding variables lowering the estimate of correlation. So, it may be surmised that higher vitamin D levels may be positively correlating with a reduced infection rate while its covariation with the adverse outcome may not be significantly correlated. It should be noted here that comprehensive vitamin D data is not available for the populations under study and within the countries different subgroups had been shown to have quite different levels of vitamin D ranging from deficiency to insufficiency [8]. Particularly, children, women, aged, people of color are more prone to having vitamin D levels lower than means for the population. Complete dependence on mean values could be problematic in driving reliable inferences for protection from COVID–19. Studies involving target groups with known vitamin D levels would be able to shed light on the reliability of the the observed protective correlation and establishing the cause and effect relationship.

A study to evaluate the effect of vitamin D levels or supplementation may be planned for SARS- CoV–2 infection using carefully matched (i.e., age, basal vitamin D level, comorbidities, sex, genetic background, disease severity, etc) control and test groups. Alternatively, relatively reliable estimates can be made using collation of the required information from health systems if needed employing a surveillance questionnaire. The outcome of the suggested retrospective or exploratory studies would possibly provide a handle to limit the impact of COVID–19 in future waves of infection as well as the countries who are still in the early or middle phase of infections, e.g., Asian countries.

The current study indicated a stronger negative correlation between mean vitamin D levels of the European populations with COVID–19 cases per million in the populations than the association shown at an earlier stage of COVID–19 pandemic (R² = 0.3751 vs R² = 0.1967)[2]. However, the vitamin D levels correlation with deaths per million population among the studied countries seemed insignificant. As vitamin D is already known to boost the immune system and play an important role in reducing respiratory disease severity [4–6], it would be safe to assume its positive interaction with

COVID–19 [3]. The biological role of vitamin D levels in avoiding infection and favorable outcomes of the COVID–19 must be thoroughly investigated through available medical records or survey-based epidemiological study with the follow-up scrutiny through controlled clinical trials for the protective effect. If found correlated, the vitamin D supplementation could allow a significant reduction in the COVID–19 impact on populations.

Funding: No specific source of funding was utilized for the current study. However, SS acknowledges the funding support from Banaras Hindu University to his laboratory.

Compliance with ethical standards

Conflict of interest: There is no conflict of interest to disclose.

Ethical statement: The study complied with the existing ethical standards.

https://worldometers.info/coronavirus/
Ilie PC, Stefanescu S, Smith L.The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clinical and Experimental Research. 2020; https://doi.org/10.1007/s40520- 020-01570-8
Ebadi M, Montano-Loza AJ (2020) Perspective: improving vitamin D status in the management of COVID- 19. Eur J Clin Nutr. https://doi.org/10.1038/s41430-020-0661-0
Martineau Adrian R, Jolliffe David A, Richard HL et al (2017) Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 356:i6583
Cannell JJ, Vieth R, Umhau JC et al (2006) Epidemic influenza and vitamin Epidemiol Infect 356:1129– 1140. https ://doi.org/10.1017/S0950268806007175
Xu J, Yang J, Chen J, Luo Q, Zhang Q, & Zhang H (2017) Vitamin D alleviates lipopolysaccharide‐induced acute lung injury via regulation of the renin‐angiotensin system. Molecular Medicine Reports, 16, 7432-7438. https://doi.org/10.3892/mmr.2017.7546
Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. (2020) SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease Cell.. https://doi.org/10.1016/j.cell.2020.02.052.
Lips P, Cashman KD, Lamberg-Allardt C, Bischoff-Ferrari HA, Obermayer-Pietsch B, Bianchi ML, Stepan J, Fuleihan GE and Bouillon R (2019) Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society. European Journal of Endocrinology 180, P23–P54

Due to technical limitations, the tables are only available as a download in the supplemental files section.

Tables.pdf

Download PDF

Journal Publication

published 01 Aug, 2020

Read the published version in Aging Clinical and Experimental Research →

Version 1

posted

You are reading this latest preprint version

Revisiting the role of vitamin D levels in the prevention of COVID-19 infection and mortality in European countries post infections peak

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Materials And Methods

Results

Discussion

Declarations

References

Tables

Supplementary Files

Status:

Journal Publication

Version 1